2017
$100M
from 11 investors over 11 rounds
DTxPharma raised $100M on March 1, 2021
Investors: Viva BioInnovator, -, Logos Global Management, LP, RA Capital Management, L.P. and Surveyor Capital
DTxPharma raised undisclosed on September 21, 2020
Investors: National Institute of Neurological Disorders and Stroke (NINDS)
DTxPharma raised $11M on January 6, 2020
Investors: -, - and Viva Biotech (Shanghai) Ltd.
DTxPharma raised $3M on May 14, 2019
Investors: -
DTxPharma raised undisclosed on June 1, 2018
Investors: -